170 related articles for article (PubMed ID: 36418670)
21. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Wang M; Li R; Zou X; Wei T; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2020 Aug; 99(35):e21996. PubMed ID: 32871952
[TBL] [Abstract][Full Text] [Related]
22. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
Zhai T; Muhanhali D; Jia X; Wu Z; Cai Z; Ling Y
Endocrine; 2019 Dec; 66(3):573-584. PubMed ID: 31332712
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
24. A prognostic nomogram for papillary thyroid cancer lymph node metastasis based on immune score.
Lu Y; Qian K; Fei M; Guo K; Shi Y; Wang Z
Front Endocrinol (Lausanne); 2022; 13():993856. PubMed ID: 36531470
[TBL] [Abstract][Full Text] [Related]
25. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
[TBL] [Abstract][Full Text] [Related]
26. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray.
Zhang ZQ; Li XJ; Liu GT; Xia Y; Zhang XY; Wen H
World J Gastroenterol; 2013 Nov; 19(43):7795-803. PubMed ID: 24282368
[TBL] [Abstract][Full Text] [Related]
27. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
28. Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis.
Kim M; Kwon CH; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Choi KU; Kim IJ; Park M; Kim BH
Endocrinol Metab (Seoul); 2021 Oct; 36(5):1086-1094. PubMed ID: 34731936
[TBL] [Abstract][Full Text] [Related]
29. Nomograms Based on Serum
Zhang Z; Cao Z; Liu R; Li Z; Wu J; Liu X; Wu M; Xu X; Liu Z
Curr Oncol; 2022 Aug; 29(9):6018-6034. PubMed ID: 36135043
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
Li W; Tang Y; Li J; Han W; Wang D; Wang Y
Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
[TBL] [Abstract][Full Text] [Related]
31. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
[TBL] [Abstract][Full Text] [Related]
33. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
Gao Y; Qu N; Zhang L; Chen JY; Ji QH
Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a single center retrospective study.
Jiwang L; Yahong L; Kai L; Bo H; Yuejiao Z; Haotian W; Tao Y
Braz J Otorhinolaryngol; 2022; 88(1):36-45. PubMed ID: 32571753
[TBL] [Abstract][Full Text] [Related]
35. Exploring risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: construction of a novel population-based predictive model.
Huang Y; Mao Y; Xu L; Wen J; Chen G
BMC Endocr Disord; 2022 Nov; 22(1):269. PubMed ID: 36329470
[TBL] [Abstract][Full Text] [Related]
36. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
Wang Y; Guan Q; Xiang J
Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics.
Shi Y; Ding Y; Li G; Wang L; Osman RA; Sun J; Qian L; Zheng G; Zhang G
Front Immunol; 2021; 12():700031. PubMed ID: 34489947
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.
Song Y; Fu LJ; Li HT; Qiu XG
Sci Rep; 2019 Apr; 9(1):5800. PubMed ID: 30967566
[TBL] [Abstract][Full Text] [Related]
39. Endoplasmic reticulum aminopeptidase 2 is highly expressed in papillary thyroid microcarcinoma with cervical lymph node metastasis.
Kim WY; Lee JB; Kim HY; Woo SU; Son GS; Bae JW
J Cancer Res Ther; 2015; 11(2):443-6. PubMed ID: 26148615
[TBL] [Abstract][Full Text] [Related]
40. Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis.
Sun YL; Zhao YX; Guan YN; You X; Zhang Y; Zhang M; Wu HY; Zhang WJ; Yao YZ
Adv Ther; 2023 Sep; 40(9):4004-4023. PubMed ID: 37422893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
